Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Astellas Pharma Inc.
Scientific Title
A Multinational, Phase 3, Randomized, Double-blind, Placebo-controlled Efficacy and Safety Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)